[3] What Lies Ahead For AOD-9604 In the future, should the cosmeceutical potential of AOD-9604 be fully realized, the implications of decreased cellulite and subcutaneous fat for health and wellness enthusiasts can be wide-ranging, including both aesthetic and health benefits
Common candidate profiles include: Adults aged 35 to 70 noticing declining energy, strength, or recovery capacity Individuals with stubborn abdominal fat and metabolic resistance despite healthy habits Patients with low-normal growth hormone or testosterone who want to avoid full hormone replacement Women in perimenopause or early menopause struggling with sleep, mood, sexual wellness, or weight gain People seeking weight loss support when diet and exercise have plateaued Peptide therapy addresses weight management from multiple angles, including appetite regulation, fat metabolism optimization, and muscle preservation
Critically, AOD-9604 does not elevate IGF-1 levels or impair glucose metabolism, distinguishing it from full-length GH
PAS Resources Healthcare Professionals Latest Blog & News PAS education programme for healthcare professionals launched
AOD 9604 functions by targeting specific receptors involved in fat metabolism, particularly those that trigger the breakdown of fats into fatty acids